1
|
Martínez Meñaca A, Barbero Herranz E, Muñoz-Esquerre M, Marín-Oto M, García Moyano M, Cascón-Hernández JA, Alonso Pérez T. Highlights del 55.° Congreso SEPAR. Open Respiratory Archives 2023. [PMID: 37497247 PMCID: PMC10369544 DOI: 10.1016/j.opresp.2022.100216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
The 55th SEPAR Congress was held in Pamplona from 2 to 4 of June 2022. Once again, it was the referral scientific meeting for specialists in pulmonology, thoracic surgery, nursing, physiotherapy, paediatric respiratory diseases and other disciplines involved in respiratory care. The Spanish Society of Pulmonology and Thoracic Surgery showed its national and international leadership in the management of respiratory diseases, which was reflected in a program with an excellent content and a high scientific level. In this review, we offer a summary of some notable aspects covered in six selected areas of interest: pulmonary vascular diseases, non-invasive mechanical ventilation and sleep disorders, asthma, chronic obstructive pulmonary disease (COPD), interstitial lung diseases (ILD), and interventional pulmonolgy and lung transplant.
Collapse
|
2
|
Ezponda A, Casanova C, Divo M, Marín-Oto M, Cabrera C, Marín JM, Bastarrika G, Pinto-Plata V, Martin-Palmero Á, Polverino F, Celli BR, de Torres JP. Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort. Respirology 2022; 27:286-293. [PMID: 35132732 PMCID: PMC9303420 DOI: 10.1111/resp.14223] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2021] [Revised: 01/11/2022] [Accepted: 01/19/2022] [Indexed: 12/16/2022]
Abstract
BACKGROUND AND OBJECTIVE The availability of chest computed tomography (CT) imaging can help diagnose comorbidities associated with chronic obstructive pulmonary disease (COPD). Their systematic identification and relationship with all-cause mortality have not been explored. Furthermore, whether their CT-detected prevalence differs from clinical diagnosis is unknown. METHODS The prevalence of 10 CT-assessed comorbidities was retrospectively determined at baseline in 379 patients (71% men) with mild to severe COPD attending pulmonary clinics. Anthropometrics, smoking history, dyspnoea, lung function, exercise capacity, BODE (BMI, Obstruction, Dyspnoea and Exercise capacity) index and exacerbations rate were recorded. The prevalence of CT-determined comorbidities was compared with that recorded clinically. Over a median of 78 months of observation, the independent association with all-cause mortality was analysed. A 'CT-comorbidome' graphically expressed the strength of their association with mortality risk. RESULTS Coronary artery calcification, emphysema and bronchiectasis were the most prevalent comorbidities (79.8%, 62.7% and 33.9%, respectively). All were underdiagnosed before CT. Coronary artery calcium (hazard ratio [HR] 2.09; 95% CI 1.03-4.26, p = 0.042), bronchiectasis (HR 2.12; 95% CI 1.05-4.26, p = 0.036) and low psoas muscle density (HR 2.61; 95% CI 1.23-5.57, p = 0.010) were independently associated with all-cause mortality and helped define the 'CT-comorbidome'. CONCLUSION This study of COPD patients shows that systematic detection of 10 CT-diagnosed comorbidities, most of which were not detected clinically, provides information of potential use to patients and clinicians caring for them.
Collapse
Affiliation(s)
- Ana Ezponda
- Radiology Department, Clínica Universidad de Navarra, Pamplona, Spain
| | - Ciro Casanova
- Pulmonary Department, Hospital Ntra Sra de Candelaria, Tenerife, Spain.,Respiratory Research Unit, Hospital Ntra Sra de Candelaria, Tenerife, Spain
| | - Miguel Divo
- Pulmonary Department, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Marta Marín-Oto
- Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Spain
| | - Carlos Cabrera
- Pulmonary Department, Hospital Universitario Doctor Negrín, Las Palmas, Spain
| | - Jose M Marín
- Pulmonary Department, Hospital Universitario Miguel Servet, Instituto Aragonés Ciencias Salud & CIBERES, Zaragoza, Spain
| | - Gorka Bastarrika
- Radiology Department, Clínica Universidad de Navarra, Pamplona, Spain
| | - Víctor Pinto-Plata
- Pulmonary Department, Baystate Medical Center, Springfield, Massachusetts, USA
| | | | - Francesca Polverino
- Asthma and Airway Disease Research Center, University of Arizona, Tucson, Arizona, USA
| | - Bartolome R Celli
- Pulmonary Department, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Juan P de Torres
- Pulmonary Department, Clínica Universidad de Navarra, Pamplona, Spain.,Respiratory Investigation Unit, Queen's University, Kingston, Ontario, Canada.,Respirology and Sleep Medicine Division, Queen's University, Kingston, Ontario, Canada
| |
Collapse
|
3
|
Recalde-Zamacona B, Tomás-Velázquez A, Campo A, Satrústegui-Alzugaray B, Fernández-Alonso M, Iñigo M, Rodríguez-Mateos M, Di Frisco M, Felgueroso C, Bertó J, Marín-Oto M, Alcaide AB, Zulueta JJ, Seijo L, Landecho MF. Chronic rhinosinusitis is associated with prolonged SARS-CoV-2 RNA shedding in upper respiratory tract samples: A case-control study. J Intern Med 2021; 289:921-925. [PMID: 33372300 DOI: 10.1111/joim.13237] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/27/2020] [Revised: 12/15/2020] [Accepted: 12/21/2020] [Indexed: 01/12/2023]
Abstract
BACKGROUND SARS-CoV-2, the COVID-19 causative agent, has infected millions of people and killed over 1.6 million worldwide. A small percentage of cases persist with prolonged positive RT-PCR on nasopharyngeal swabs. The aim of this study was to determine risk factors for prolonged viral shedding amongst patient's basal clinical conditions. METHODS We have evaluated all 513 patients attended in our hospital between 1 March and 1 July. We have selected all 18 patients with prolonged viral shedding and compared them with 36 sex-matched randomly selected controls. Demographic, treatment and clinical data were systematically collected. RESULTS Global median duration of viral clearance was 25.5 days (n = 54; IQR, 22-39.3 days), 48.5 days in cases (IQR 38.7-54.9 days) and 23 days in controls (IQR 20.2-25.7), respectively. There were not observed differences in demographic, symptoms or treatment data between groups. Chronic rhinosinusitis and atopy were more common in patients with prolonged viral shedding (67%) compared with controls (11% and 25% respectively) (P < 0.001 and P = 0.003). The use of inhaled corticosteroids was also more frequent in case group (P = 0.007). Multivariate analysis indicated that CRS (odds ratio [OR], 18.78; 95% confidence interval [95%CI], 3.89-90.59; P < 0.001) was independently associated with prolonged SARS-CoV-2 RNA shedding in URT samples, after adjusting for initial PCR Ct values. CONCLUSION We found that chronic rhinosinusitis and atopy might be associated with increased risk of prolonged viral shedding. If confirmed in prospective trials, this finding might have clinical implications for quarantine duration due to increased risk of pandemic spread.
Collapse
Affiliation(s)
- B Recalde-Zamacona
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Pulmonary Medicine Department, Clinica, Pamplona, Spain
| | - A Tomás-Velázquez
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Dermatology Department, Clinica Universidad de Navarra, Pamplona, Spain
| | - A Campo
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Pulmonary Medicine Department, Clinica, Pamplona, Spain
| | | | - M Fernández-Alonso
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Microbiology and Infectious Diseases Division, Clinica, Pamplona, Spain
| | - M Iñigo
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Microbiology and Infectious Diseases Division, Clinica, Pamplona, Spain
| | - M Rodríguez-Mateos
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Microbiology and Infectious Diseases Division, Clinica, Pamplona, Spain
| | - M Di Frisco
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Pulmonary Medicine Department, Clinica, Pamplona, Spain
| | - C Felgueroso
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Pulmonary Medicine Department, Clinica, Pamplona, Spain
| | - J Bertó
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Pulmonary Medicine Department, Clinica, Pamplona, Spain
| | - M Marín-Oto
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Pulmonary Medicine Department, Clinica, Pamplona, Spain
| | - A B Alcaide
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Pulmonary Medicine Department, Clinica, Pamplona, Spain
| | - J J Zulueta
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Pulmonary Medicine Department, Clinica, Pamplona, Spain
| | - L Seijo
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Pulmonary Medicine Department, Clinica, Pamplona, Spain
| | - M F Landecho
- From the, Covid19 Department, Clinica, Pamplona, Spain.,Internal Medicine department, Clinica Universidad de Navarra, Pamplona, Spain
| |
Collapse
|
4
|
Recalde-Zamacona B, Ezponda A, Zulueta JJ, Marín-Oto M, Alcaide AB, Campo A, Bertó J. Bronchial Artery Pseudoaneurysm and Mediastinal Hematoma after EBUS-TBNA. Arch Bronconeumol 2020; 57:142-143. [PMID: 32829998 DOI: 10.1016/j.arbres.2020.07.018] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2020] [Revised: 07/13/2020] [Accepted: 07/18/2020] [Indexed: 12/14/2022]
Affiliation(s)
| | - Ana Ezponda
- Departamento de Radiología, Clínica Universidad de Navarra, Pamplona, Navarra, España
| | - Javier J Zulueta
- Departamento de Neumología, Clínica Universidad de Navarra, Pamplona, Navarra, España
| | - Marta Marín-Oto
- Departamento de Neumología, Clínica Universidad de Navarra, Pamplona, Navarra, España
| | - Ana Belén Alcaide
- Departamento de Neumología, Clínica Universidad de Navarra, Pamplona, Navarra, España
| | - Aránzazu Campo
- Departamento de Neumología, Clínica Universidad de Navarra, Pamplona, Navarra, España
| | - Juan Bertó
- Departamento de Neumología, Clínica Universidad de Navarra, Pamplona, Navarra, España
| |
Collapse
|